FCIM
ZBH icon

Fairview Capital Investment Management’s Zimmer Biomet ZBH Stock Holding History

Fairview Capital Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,063
Closed -$746K – 166
2024
Q4 		$746K Sell
7,063
-28,779
-80% -$3.09M 0.04% 101
2024
Q3 		$3.87M Sell
35,842
-72,899
-67% -$7.96M 0.21% 63
2024
Q2 		$11.8M Sell
108,741
-1,729
-2% -$204K 0.66% 32
2024
Q1 		$14.6M Buy
110,470
+24,657
+29% +$3.08M 0.82% 31
2023
Q4 		$10.4M Sell
85,813
-2,998
-3% -$335K 0.62% 36
2023
Q3 		$9.97M Sell
88,811
-17,382
-16% -$2.21M 0.64% 34
2023
Q2 		$15.5M Buy
106,193
+300
+0.3% +$40.8K 0.98% 27
2023
Q1 		$13.7M Buy
105,893
+2,664
+3% +$334K 0.89% 30
2022
Q4 		$13.2M Sell
103,229
-2,828
-3% -$328K 0.9% 30
2022
Q3 		$11.1M Buy
106,057
+7,160
+7% +$786K 0.79% 33
2022
Q2 		$10.4M Buy
98,897
+926
+0.9% +$110K 0.72% 36
2022
Q1 		$12.5M Buy
97,971
+74,553
+318% +$8.99M 0.78% 30
2021
Q4 		$2.89M Buy
+23,418
New +$3.06M 0.18% 59

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fairview Capital Investment Management's ZBH Position: Q1 2025 in Review

Fairview Capital Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 7,063 shares — an estimated $746K sold.

Fairview Capital Investment Management first reported a position in ZBH in Q4 2021 and held it in 13 quarters. The position peaked at $15.5M in Q2 2023. 1,001 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Fairview Capital Investment Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Fairview Capital Investment Management sold 7,063 Zimmer Biomet shares in Q1 2025, an estimated $746K.
  • Fairview Capital Investment Management first reported a position in Zimmer Biomet in Q4 2021 and held it in 13 quarters.
  • Fairview Capital Investment Management's Zimmer Biomet position peaked at $15.5M in Q2 2023.
  • 1,001 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Fairview Capital Investment Management's 13F filing for Q1 2025, filed 15 May 2025.